Riskpilot← Back to searchSign inGet full accessMB Scientific AB
ABActiveOrg 5566058425Fålhagsleden 61 BvManufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 200110-19 employees
Revenue 2024
SEK 28,1M
+1% vs 2023
EBITDA margin
8.8%
-11% vs 2023
Equity ratio
44.8%
Financial strength
Net profit 2024
SEK 1,4M
+40% vs 2023
| Revenue | SEK 28,1M | +1% |
| EBITDA | SEK 2,5M | -11% |
| Net profit | SEK 1,4M | +40% |
| Total assets | SEK 19,7M | +4% |
| Equity | SEK 8,8M | +5% |
| Employees | — | — |
Legal name
MB Scientific AB
Org number
5566058425
Legal form
Aktiebolag
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
24 januari 2001
Share capital
SEK 100 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Baltzer, Nils Peter Oscar Matsuki, Mitsuse
Company purpose
Bolaget skall utveckla, tillverka och sälja vetenskapliga instrument samt tillhandahålla konsulttjänster rörande marknadsföring och försäljning mot Japan samt därmed förenlig verksamhet
Address
Fålhagsleden 61 Bv
Phone
+4618572683
Email
info@mbscientific.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 968 | 10 463 | 23 303 | 27 881 | 28 074 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 808 | −387 | 4 159 | 2 774 | 2 476 |
| Depreciation & amort. | −96 | −93 | −91 | −45 | −46 |
| EBIT | 3 712 | −480 | 4 068 | 2 729 | 2 430 |
| Net financials | −16 | 78 | 88 | −572 | 63 |
| Profit before tax | 2 735 | 32 | 3 117 | 1 446 | 1 821 |
| Tax | −598 | −22 | −659 | −439 | −415 |
| Net profit | 2 137 | 10 | 2 458 | 1 007 | 1 406 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 446 | 24 615 | 21 498 | 18 996 | 19 721 |
| Equity | 5 947 | 5 957 | 8 415 | 8 422 | 8 827 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 087 | 17 691 | 11 087 | 7 868 | 7 515 |
| Total debt | 6 087 | 17 691 | 11 087 | 7 868 | 7 515 |
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
20202024
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
15.9%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
5.0%
This company
8.1%
Market median
-38% vs market
20202024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MM Chief Executive Officer | Chief Executive Officer | 2022 |
JK | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MB Scientific Holding AB
MB Scientific AB Board members of MB Scientific AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mitsuse Matsuki | Chief Executive Officer | 0 companies |
| Johanna Katarina Boive | Audit | 0 companies |
| Stig Anders Lejon | Deputy Board Member | 0 companies |
| Nils Peter Oscar Baltzer | Chairman | 0 companies |